 - Patients previously treated with centrally active acetylchlinesterase AChE inhibitors e.g., physostigmine, tacrine, metrifonate, galantamine, rivastigmine, donepezil except the medication in the Aricept double-blind study E2020-E044-316 NCT00165815. 